June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Structure-Function Associations between Contrast Sensitivity (CS) and Vascular Metrics on Wide Field Swept Source Optical Coherence Tomography Angiography (WF SS OCTA) across stages of Diabetic Retinopathy
Author Affiliations & Notes
  • Filippos Vingopoulos
    Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Grace Baldwin
    Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Raviv Katz
    Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Itika Garg
    Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Ying Cui
    Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences,, Guangzhou, China
  • Jade Yunkyung Moon
    Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Nimesh A Patel
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • David M. Wu
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Deeba Husain
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Joan W Miller
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Leo A Kim
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • John B Miller
    Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Filippos Vingopoulos None; Grace Baldwin None; Raviv Katz None; Itika Garg None; Ying Cui None; Jade Moon None; Nimesh Patel Alimera Sciences, Code C (Consultant/Contractor), Alcon, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor), Genentech, Code C (Consultant/Contractor); David Wu Massachusetts Eye and Ear / Harvard Ophthalmology, Code P (Patent); Deeba Husain Allergan, Code C (Consultant/Contractor), Genentech, Code C (Consultant/Contractor), Omeicos Pharmaceuticals, Code C (Consultant/Contractor), NEI, Code F (Financial Support), Lions VisionGift, Code F (Financial Support), Commonwealth Grant, Code F (Financial Support), Lions International, Code F (Financial Support), Syneos LLC, and the Macula Society , Code F (Financial Support); Joan Miller Heidelberg Engineering, Code C (Consultant/Contractor), Sunovion, Code C (Consultant/Contractor), KalVista Pharmaceuticals, Code C (Consultant/Contractor), ONL Therapeutics, Code C (Consultant/Contractor), Lowy Medical Research Institute, Ltd, Code F (Financial Support), ONL, Valeant, Massachusetts Eye and Ear, Code P (Patent); Leo Kim NEI, Code F (Financial Support), CureVac AG, Code F (Financial Support), Pykus Therapeutics, Code F (Financial Support); Demetrios Vavvas Valitor, Code C (Consultant/Contractor), Olix Pharmaceuticals, Code C (Consultant/Contractor), NIE, Code F (Financial Support), NIH, Code F (Financial Support), Research to Prevent Blindness, Code F (Financial Support), Loefflers Family Foundation, Code F (Financial Support), Yeatts Family Foundation, Code F (Financial Support), Alcon Research Institute, Code F (Financial Support); John Miller Alcon, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor), Carl Zeiss, Code C (Consultant/Contractor), Sunovion, Code C (Consultant/Contractor), Genentech, Code C (Consultant/Contractor)
  • Footnotes
    Support  Lions International Fund (Grant 530125 and 530869). The funding organization had no role in the design or conduct of this research.
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2206 – F0269. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Filippos Vingopoulos, Grace Baldwin, Raviv Katz, Itika Garg, Ying Cui, Jade Yunkyung Moon, Nimesh A Patel, David M. Wu, Deeba Husain, Joan W Miller, Leo A Kim, Demetrios G. Vavvas, John B Miller; Structure-Function Associations between Contrast Sensitivity (CS) and Vascular Metrics on Wide Field Swept Source Optical Coherence Tomography Angiography (WF SS OCTA) across stages of Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2206 – F0269.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate structure-function associations between CS and vascular metrics on WF SS OCTA across stages of non proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR), in the absence of diabetic macular edema (DME).

Methods : This prospective observational study included 95 eyes of 78 patients, including 20 mild NPDR eyes, 12 moderate/severe NPDR, 22 PDR, 14 diabetic eyes without DR (DMnoDR), and 27 control eyes. LogMAR Visual Acuity (VA) was measured. CS was measured with the active learning quantitative CS function (qCSF) Manifold Contrast Vision Meter (Adaptive Sensory Technology) and outcomes included Area under the Log CSF (AULCSF) and contrast sensitivity (CS) thresholds at 1-18 cycles per degree (cpd). All eyes were imaged using WF SS OCTA (Plex Elite 9000, Carl Zeiss Meditec). The ARI Network (Zeiss Portal v5.4) delivered vascular metrics, including vessel density (VD) and vessel skeletonized density (VSD) in the superficial and deep capillary plexus (SCP, DCP) on 6x6 mm images. Mixed-effects multivariate regression models were used to evaluate associations between CS functional outcomes and WF SS OCTA structural outcomes across DR stages.

Results : Controlling for age and lens status in the whole cohort, VD in the SCP was significantly associated with LogMAR VA (β= -0.02, P<0.001), AULCSF (β= 0.03, P<0.001), and CS thresholds at 1cpd (β= 0.02, P=0.004), 1.5cpd (β= 0.02, P=0.005), 3cpd (β= 0.03, P=0.009), 6cpd (β= 0.04, P=0.002), 12cpd (β= 0.04, P= 0.002) and 18cpd (β= 0.01, P= 0.044).VSD in the SCP was associated with LogMAR (β= -1.19, P= 0.010), AULCSF (β= 1.18, P= 0.010), and CS at 1cpd (β= 1.00, P=0.008), 1.5cpd (β= 0.91, P=0.016), 3cpd (β= 0.89, P= 0.039), 6cpd (β= 1.5, P= 0.011) and 12cpd (β= 1.44, P= 0.008); VD in the DCP was associated with LogMAR (β= -0.01, P=0.008), AULCSF (β= 0.01, P= 0.066) and 12cpd (β=0.18, P=0.013) and VSD in the DCP with LogMAR (β= -0.49, P=0.013), AULCSF (β= 0.47, P= 0.099), 12cpd (β=0.82, P=0.021).

Conclusions : We present novel structure-function associations across stages of DR without DME, leveraging WF SS OCTA imaging and CS metrics. The progressive decline in the OCTA vascular metrics across DR stages seems to be associated with equally large changes in contrast sensitivity metrics as in VA.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×